Board of Directors

 

Rx&D has an effective and engaged Board of Directors that enables member companies to achieve common objectives.

Executive Committee/Officers

Chair
Mark Lievonen, President, Sanofi Pasteur Limited
First Vice-Chair
John Helou, President, Pfizer Canada Inc.
Second Vice Chair
Felipe Pastrana, General Manager, AbbVie Corporation
Treasurer
Michael Tremblay, President, Astellas Pharma Canada, Inc.
Member at Large
Elaine Campbell, President & CEO, AstraZeneca Canada Inc. 
Immediate Past Chair
Chris Halyk, President, Janssen Inc.
Ex-Officio

Ronnie Miller, President & CEO, Hoffmann-La Roche Limited

President Russell Williams, Canada’s Research-Based Pharmaceutical Companies (Rx&D)

Directors

Mark Beaudet, Interim President & CEO, Paladin Labs Inc.

Dr. Thomas R. Cannell, President & Managing Director, Merck Canada Inc.

Patrick Cashman, President and General Manager, Lundbeck Canada Inc.

Mike Egli, President & CEO, Takeda Canada Inc.

Frédéric Fasano, Chief Executive Officer, Servier Canada Inc.

Gilles Gagnon, President & CEO, Ceapro Inc.

Barry Hayter, General Manager, Abbott Laboratories, Limited

Helen Jordan, General Manager and Vice-President, Amgen Canada Inc.

Vince Lamanna, President, Novo Nordisk Canada Inc.

Craig Landau, President & CEO, Purdue Pharma

Christian Lauterbach, President & CEO, Bayer Inc.

Paul Lirette, President, GlaxoSmithKline Inc.

Tim Maloney, President, Novartis Pharmaceuticals Canada Inc.

Lisa Matar, President & General Manager, Eli Lilly Canada inc.

Allison Rosental, General Manager, Otsuka Canada Pharmaceutical Inc. (OCPI)

Oliver Technow, President & General Manager, Eisai Limited

Revised: April 11, 2014